These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23135527)

  • 1. Pharmacokinetic study and effectiveness evaluation of slow-release PLGA-5-fluorouracil microsphere.
    Li J; Pu Y; Wang S; Ding M; Chen D; Zhu M
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):351-9. PubMed ID: 23135527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effectiveness of slow-release PLGA-oxaliplatin microsphere on human colorectal tumor-bearing mice.
    Li JQ; Wang SL; Xu F; Liu ZY; Li R
    Anticancer Drugs; 2010 Jul; 21(6):600-8. PubMed ID: 20527722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
    Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
    Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
    Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
    J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
    Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P
    Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model.
    Kim TK; Burgess DJ
    J Pharm Pharmacol; 2002 Jul; 54(7):897-905. PubMed ID: 12162707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of amifostine polylactide-co-glycolide microspheres and its irradiation protective to mouse through oral administration.
    Lu TL; Sun WG; Zhao W; Chen T
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1473-80. PubMed ID: 21721846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An experimental study on ectopic osteogenesis of autologous micromorselized bone compounded with slow-released rhBMP-2/PLGA microsphere].
    Ji Y; Yan J; Xu G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Nov; 21(11):1184-90. PubMed ID: 18069471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
    Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
    Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
    Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M
    Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of GRF encapsulated in PLGA microspheres in animal skeletal muscle induces body weight gain.
    Zhang YL; Ren XH; Liu SC; Dai JW; Hao LL; Jiang QY
    Anim Biotechnol; 2007; 18(3):163-75. PubMed ID: 17612839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
    Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
    Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis.
    Daugherty AL; Rangell LK; Eckert R; Zavala-Solorio J; Peale F; Mrsny RJ
    Eur J Pharm Biopharm; 2011 Jun; 78(2):289-97. PubMed ID: 21426936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.